| Code | Description | Claims | Beneficiaries | Total Paid |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
18,541 |
15,815 |
$2.37M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,884 |
5,170 |
$1.23M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,113 |
5,354 |
$905K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,870 |
3,421 |
$524K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,682 |
1,469 |
$517K |
| 80053 |
Comprehensive metabolic panel |
6,442 |
5,484 |
$222K |
| 84484 |
|
3,705 |
2,970 |
$202K |
| G0378 |
Hospital observation service, per hour |
424 |
350 |
$198K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,580 |
8,877 |
$193K |
| 84702 |
|
3,157 |
2,648 |
$167K |
| 87490 |
|
960 |
884 |
$146K |
| 71045 |
Radiologic examination, chest; single view |
3,733 |
3,244 |
$144K |
| 87590 |
|
952 |
875 |
$134K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,009 |
426 |
$106K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,993 |
3,466 |
$105K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,486 |
1,176 |
$105K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
547 |
435 |
$90K |
| 76830 |
Ultrasound, transvaginal |
283 |
239 |
$90K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
955 |
863 |
$88K |
| 71046 |
Radiologic examination, chest; 2 views |
1,360 |
1,282 |
$83K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
780 |
708 |
$80K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
737 |
531 |
$76K |
| 87905 |
|
793 |
721 |
$73K |
| 83690 |
|
3,280 |
2,835 |
$66K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,086 |
3,633 |
$66K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
248 |
206 |
$63K |
| 0223U |
|
153 |
135 |
$57K |
| 87581 |
|
525 |
426 |
$52K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
972 |
696 |
$46K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
809 |
737 |
$42K |
| 82962 |
|
1,494 |
1,206 |
$37K |
| 81015 |
|
2,231 |
1,960 |
$34K |
| 87276 |
|
451 |
428 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,234 |
1,045 |
$26K |
| 81002 |
|
1,479 |
1,333 |
$24K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
63 |
58 |
$23K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,412 |
1,154 |
$17K |
| 83518 |
|
437 |
418 |
$15K |
| 87081 |
|
184 |
176 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
85 |
79 |
$12K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
85 |
79 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
60 |
50 |
$12K |
| 85378 |
|
312 |
274 |
$12K |
| 73562 |
|
186 |
165 |
$11K |
| 81001 |
|
875 |
804 |
$11K |
| 83880 |
|
229 |
200 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,097 |
2,678 |
$9K |
| 90715 |
|
76 |
66 |
$8K |
| 83735 |
|
566 |
493 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
82 |
81 |
$7K |
| 73630 |
|
120 |
118 |
$7K |
| 83605 |
|
125 |
109 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,946 |
1,592 |
$5K |
| 81003 |
|
398 |
381 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
58 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
668 |
465 |
$4K |
| 85610 |
|
146 |
131 |
$4K |
| 93971 |
|
12 |
12 |
$3K |
| 81025 |
|
120 |
108 |
$3K |
| 86803 |
|
63 |
62 |
$3K |
| 85730 |
|
97 |
88 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
275 |
248 |
$2K |
| 84703 |
|
83 |
75 |
$2K |
| 73610 |
|
29 |
29 |
$2K |
| 73130 |
|
36 |
31 |
$2K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
646 |
576 |
$2K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
348 |
326 |
$2K |
| 73110 |
|
16 |
15 |
$1K |
| 73030 |
|
39 |
37 |
$1K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
695 |
502 |
$986.28 |
| 86901 |
|
43 |
26 |
$748.62 |
| 87220 |
|
15 |
12 |
$606.10 |
| 94799 |
|
12 |
12 |
$602.38 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$458.13 |
| 80320 |
|
12 |
12 |
$414.19 |
| 87210 |
|
16 |
14 |
$355.20 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
536 |
439 |
$334.65 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
121 |
93 |
$262.91 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
292 |
253 |
$187.65 |
| J7050 |
Infusion, normal saline solution, 250 cc |
17 |
13 |
$36.69 |
| J2060 |
Injection, lorazepam, 2 mg |
23 |
12 |
$34.13 |
| 0637 |
|
42 |
24 |
$0.00 |
| 0250 |
|
223 |
122 |
$0.00 |
| 0270 |
|
239 |
225 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
12 |
12 |
$0.00 |